Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ventricular arrhythmias: current concepts.

P F Nestico, J Morganroth

    Comprehensive Therapy
    |September 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Conventional antiarrhythmic drugs and tocainide are key for treating ventricular arrhythmias. Understanding their mechanisms, pharmacokinetics, dosages, and side effects is crucial for effective patient care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A thorough electrocardiogram study of edoxaban, a novel factor Xa inhibitor.

    Journal of clinical pharmacology·2011
    Same author

    Effects of the selective alpha 1a-adrenoceptor antagonist silodosin on ECGs of healthy men in a randomized, double-blind, placebo- and moxifloxacin-controlled study.

    Clinical pharmacology and therapeutics·2010
    Same author

    Evaluation and management of cardiac safety using the electrocardiogram in oncology clinical trials: focus on cardiac repolarization (QTc interval).

    Clinical pharmacology and therapeutics·2009
    Same author

    Cardiac repolarization and the safety of new drugs defined by electrocardiography.

    Clinical pharmacology and therapeutics·2006
    Same author

    Evaluation of the effect on cardiac repolarization (QTc interval) of oncologic drugs.

    Ernst Schering Research Foundation workshop·2006
    Same author

    Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval.

    British journal of clinical pharmacology·2001
    Same journal

    Heparin-induced thrombocytopenia and thrombosis.

    Comprehensive therapy·2011
    Same journal

    Antiplatelet therapy in cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Genetics of cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Septic renal vein thrombosis complicated by septic pulmonary embolism.

    Comprehensive therapy·2011
    Same journal

    Gout and hyperuricemia.

    Comprehensive therapy·2011
    Same journal

    Problems with computerized health records.

    Comprehensive therapy·2011
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiology

    Background:

    • Ventricular arrhythmias pose significant clinical challenges.
    • Conventional antiarrhythmic agents are mainstays in treatment.
    • Tocainide represents an additional therapeutic option.

    Purpose of the Study:

    • To review the essential characteristics of conventional antiarrhythmic drugs and tocainide.
    • To emphasize the importance of understanding drug properties for optimal use.
    • To guide clinicians in managing ventricular arrhythmias.

    Main Methods:

    • Literature review of antiarrhythmic agents.
    • Analysis of pharmacokinetic and pharmacodynamic data.
    • Summary of clinical application guidelines.

    Main Results:

    Related Experiment Videos

    • Established antiarrhythmic drugs exhibit diverse mechanisms of action.
    • Tocainide shares properties with other Class Ib agents.
    • Comprehensive knowledge of each drug's profile is vital.

    Conclusions:

    • Familiarity with mechanism of action, pharmacokinetics, dosage, and adverse effects is essential.
    • Proper utilization of these agents improves ventricular arrhythmia management.
    • Informed clinical decisions enhance patient outcomes.